Evidence map›Paper›PMID 38762724›Full record

ArticleMolecular brain2024

Spatiotemporal dynamics of the CD11c

Kohei Nomaki, Risako Fujikawa, Takahiro Masuda, Makoto Tsuda

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Molecular brain, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Review
  3. Microglia in Brain Aging and Age-Related Diseases: Friends or Foes?International journal of molecular sciences · 2025
    Review
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Kohei NomakiDepartment of Molecular and System Pharmacology, Graduate School of Pharmaceutical Sciences, Kyushu University, 3-1-1 Maidashi, Higashi-ku, Fukuoka, 812-8582, Japan.
Risako FujikawaDepartment of Molecular and System Pharmacology, Graduate School of Pharmaceutical Sciences, Kyushu University, 3-1-1 Maidashi, Higashi-ku, Fukuoka, 812-8582, Japan.
Takahiro MasudaDivision of Molecular Neuroimmunology, Medical Institute of Bioregulation, Kyushu University, 3-1-1 Maidashi, Higashi-ku, Fukuoka, 812-8582, Japan.
Makoto TsudaDepartment of Molecular and System Pharmacology, Graduate School of Pharmaceutical Sciences, Kyushu University, 3-1-1 Maidashi, Higashi-ku, Fukuoka, 812-8582, Japan. tsuda@phar.kyushu-u.ac.jp.ORCID 0000-0003-0585-9570

Funding

AMED 23gm1510013h, JP23ama121031AMED JP20gm6310016, JP21wm0425001, JP23gm1910004, JP23jf0126004Astellas Foundation for Research on Metabolic Disorders Astellas Foundation for Research on Metabolic DisordersDaiichi Sankyo Foundation of Life Science Daiichi Sankyo Foundation of Life ScienceJSPS JP19H05658, JP20H05900JSPS JP21H02752, JP22H05062Mitsubishi Foundation Mitsubishi FoundationMochida Memorial Foundation for Medical and Pharmaceutical Research Mochida Memorial Foundation for Medical and Pharmaceutical ResearchOno Pharmaceutical Foundation for Oncology, Immunology and Neurology Ono Pharmaceutical Foundation for Oncology, Immunology and NeurologyTakeda Science Foundation Takeda Science FoundationThe Nakajima Foundation The Nakajima FoundationUehara Memorial Foundation Uehara Memorial Foundation
6 · The paper itself

Abstract

CD11c-positive (CD11c

Indexed as

BrainMice, TransgenicMicrogliaSpinal CordAgingAnimalsAnimals, NewbornCD11c AntigenMiceMice, Inbred C57BLSpatio-Temporal AnalysisCD11c AntigenAdultBrainCD11c+ microgliaMousePre/postnatal developmentSpatiotemporal dynamicsSpinal cord

Identifiers

PMID38762724
PMCPMC11102220

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.